According to LifeMD's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -57.3. At the end of 2024 the company had a P/S ratio of 1.06.
Year | P/S ratio | Change |
---|---|---|
2024 | 1.06 | -50.05% |
2023 | 2.13 | 315.65% |
2022 | 0.5126 | -59.79% |
2021 | 1.27 | -62.91% |
2020 | 3.44 | 597.71% |
2019 | 0.4926 | -39.15% |
2018 | 0.8095 | -76.67% |
2017 | 3.47 | 99.55% |
2016 | 1.74 | -45.24% |
2015 | 3.17 | -26.22% |
2014 | 4.30 | -55.56% |
2013 | 9.68 |